During the first quarter of 2024, cash used in operations was $7.7 million, which was affected by the unfavorable gross margin in the quarter and the timing of working capital utilization.
Financial Guidance
Following the results of Q1’24, Lifeward continues to expect revenue of between $28 to $32 million in 2024 vs. $34.57M consensus. For the second quarter, Lifeward expects sequential improvement in revenue (vs. $6.68M consensus) as a result of the expanded access to ReWalk systems from the finalized Medicare reimbursement and the improving sales traction of the new commercial team.
